top of page
ANALLISA
PHASE II STUDY TO ASSESS THE EFFICACY OF NIRAPARIB RECHALLENGE AFTER SURGERY IN OVARIAN CANCER PATIENTS WITH OLIGOMETASTATIC PROGRESSION (THE ANALLISA STUDY)
Endometrioid Ovarian Cancer
II
30
9
Spain
Recruitment
CLINICAL TRIAL DETAILS
THE PRIMARY OBJECTIVE IS TO EVALUATE PROGRESSION-FREE SURVIVAL (PFS) OF NIRAPARIB RECHALLENGE IN OC PATIENTS WITH OMP AND NO RESIDUAL DISEASE AFTER SECONDARY CYTOREDUCTIVE SURGERY.
ANALLISA AT CLINICALTRIALS.GOV
TUMOR TYPE
PHASE
N
SITES
COUNTRY
STATUS
TRIAL RESUME
Dr. Alfonso Cortés, PI of the ANALLISA trial
ANALLISA SITES
SPAIN
Hospital Universitario Ramón y Cajal
SPAIN
Hospital Universitario Jaén
SPAIN
Hospital Universitario La Paz
SPAIN
Vall d’Hebron Institute of Oncology
SPAIN
Hospital Universitario San Juan de Reus
SPAIN
Hospital Universitario 12 de Octubre
SPAIN
Hospital Universitario de A Coruña (CHUAC)
SPAIN
Hospital Universitario Virgen Macarena
SPAIN
Hospital Arnau de Vilanova de Valencia
bottom of page